The use of substituted amides for modulating the activity of 11β-hydroxysteroid dehydro-genase type 1 (11βHSD1) and the use of these compounds as pharmaceutical composi-tions, are described. Also a novel class of substituted amides, their use in therapy, phar-maceutical compositions comprising the compounds, as well as their use in the manufac-ture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment of a range of medical disorders where a decreased intracellular concentration of active gluco-corticoid is desirable.
The invention provides a stable detection kit of total bile acid. The kit comprises a reagent R1 and a reagent R2, wherein the reagent R1 comprises the following components: a buffering solution, beta-thionicotinamide adenine dinucleotide, a surface active agent, a stabilizing agent and a preservative; the reagent R2 comprises the following components: a buffering solution, reduction type coenzyme I (NADH), 3alpha-hydroxysteroid, a surface active agent, antioxidantenzyme, a stabilizing agent and a preservative. The stable detection kit provided by the invention has the advantages that since the antioxidantenzyme is added into the reagents, NADH can be stored for a long time, the influence caused by more interference components in the reaction process is eliminated, so that the NADH can be utilized efficiently, the speed of circulating reaction is increased, the detection accuracy is improved, the sensitivity is high, the linear range is wide, simultaneously, the used amount of main reaction materials can be reduced and the cost of the reagents is reduced.